Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03434327 · ClinicalTrials.gov registry record · NA

Training and Parkinson's

A NA study of Parkinson Disease and Weight-Lifting Exercise Program, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT03434327 is a NA study of Parkinson Disease and Weight-Lifting Exercise Program that has completed, run by University of Miami. The registered enrollment target is 35 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03434327, a NA study of Parkinson Disease and Weight-Lifting Exercise Program, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

The purpose of the current study is to compare the impacts of specifically designed power training and strength training programs on function and physical performance in Parkinson's patients. Specific aims are to examine the impact of these interventions on performance variables such as balance, strength, power, posture, gait and physical function.

Interventions

  • OTHER Strength Training
  • OTHER Power Training

Study Locations (1)

Florida

  • Max Orovitz Laboratories - Coral Gables

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2018-02-01
Est. Completion 2018-08-15
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT03434327

The ClinicalTrials.gov registry entry for NCT03434327 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Strength Training is the first listed.

NCT03434327 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03434327 about?

NCT03434327 is a clinical study titled "Training and Parkinson's". The purpose of the current study is to compare the impacts of specifically designed power training and strength training programs on function and physical performance in Parkinson's patients. Specific aims are to examine the impact of these interventions on performance variables such as balance, str...

What is the current status of trial NCT03434327?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-02-01. Estimated completion is 2018-08-15.

What conditions does trial NCT03434327 study?

This clinical trial studies the following conditions: Parkinson Disease, Weight-Lifting Exercise Program.

What interventions are being tested in trial NCT03434327?

The interventions under investigation include: Strength Training (OTHER), Power Training (OTHER).

Who is sponsoring clinical trial NCT03434327?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03434327 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.